Sebetralstat

N/A

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NameSebetralstat
Drug Alias Name塞贝特拉司他EkterlyKVD-900
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsAngioedemas, Hereditary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/07/03
Country/TerritoryCzechiaBulgariaCanada +[27] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVantia Therapeutics Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesDRI Healthcare TrustKalvista Pharmaceuticals (Ireland) LtdKalvista Pharmaceuticals Inc +[5] 
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG